Optiflex Sodium Hyaluronate  from Moss Vision Inc Ltd
  • Osteoarthritis (OA) is the most common joint disorder in the world affecting 200 million people worldwide. It is most frequent cause of pain, loss of function and disability in adults. Hyaluronic acid viscosupplementation is an increasingly popular non-pharmacological treatment for knee osteoarthritis. Intra-articular injections of synthetic hyaluronic acid are given to restore the natural mechanical properties of synovial fluid.
  • OPTIVISC viscosupplementationrange of products has been designed with high molecular weight Hyaluronic Acid for an effective management of OA. OPTIVISC viscosupplement products provide joint pain relieve and improvement of joint mobility